Stock Market News For Mar 7, 2019

 | Mar 06, 2019 09:49PM ET

Benchmarks ended in the red on Wednesday after a slew of weak economic reports weighed on the markets. Fed’s Beige Book provided a rather gloomy picture of the U.S. economy in the period between January and February, citing partial government shutdown as the primary reason behind such a slowdown. Meanwhile, Trump urged U.S. negotiators to strike a trade with China so that markets might finally find the catalyst required for growth.

The Dow Jones Industrial Average (DJI) decreased 0.5%, to close at 25,673.46. The S&P 500 decreased 0.7% to close at 2,771.45. The tech-laden Nasdaq Composite Index closed at 7,505.92, losing 0.09%. The fear-gauge CBOE Volatility Index (VIX) increased 6.8% to close at 15.74. Decliners outnumbered advancers on the NYSE by a 1.96-to-1 ratio. On Nasdaq, a 2.47-to-1 ratio favored declining issues.

How Did the Benchmarks Perform?

The Dow lost 133.2 points to end the session in negative territory. Losses for the 30-stock index were buoyed by a dip of about 3.6% in the shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) . The Dow Transports dipped 0.5% to post its ninth decline on the trot, marking the longest streak of losses since 2009.

The S&P 500 declined 18.2 points to also end in the red. Of the 11 major sectors of the S&P 500, nine ended in the negative territory, with healthcare and energy leading the decliners. The Health Care Select Sector SPDR ETF (NYSE:XLV) and the Energy Select Sector SPDR ETF (NYSE:XLE) lost 1.5% and 1.3%, respectively.

Shares of Nektar Therapeutics (NASDAQ:NKTR) and HCA Healthcare, Inc. (NYSE:HCA) declined 5.2% and 4.9%, respectively and weighed on the broader index. Further, oil prices slid 0.6% after the Energy Information Administration announced that U.S. crude inventories increased to 7.1 million barrels last week. Such developments also weighed on the S&P 500.

Meanwhile, the Nasdaq lost 70.4 points to also end in negative territory. This marked the tech-laden index’s first three-day decline this year. You can see Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes